Table of Contents
ISRN AIDS
Volume 2013, Article ID 287269, 5 pages
http://dx.doi.org/10.1155/2013/287269
Review Article

Rapid Point-of-Care Testing for Detection of HIV and Clinical Monitoring

1Department of Microbiology, SGT Medical College, Budhera, Gurgaon, Haryana 123505, India
2Shri Guru Gobind Singh Tricentenary Medical College, Village Budhera, Gurgaon, Haryana 123505, India
3Department of Pathology, SGT Medical College, Budhera, Gurgaon, Haryana 123505, India

Received 7 April 2013; Accepted 2 May 2013

Academic Editors: D. Aunis, L. Gray, C. Petrovas, J. Poudrier, and A. B. Williams

Copyright © 2013 D. R. Arora et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. L. Higgins, C. Galavott, K. R. O’Reilly et al., “Evidence for the effects of HIV antibody counseling and testing on risk behaviours,” Journal of American Medical Association, vol. 266, no. 17, pp. 2419–2429, 1991. View at Publisher · View at Google Scholar
  2. M. J. Rotheram-Borus, P. A. Newman, and M. A. Etzel, “Effective detection of HIV,” Journal of Acquired Immune Deficiency Syndromes, vol. 25, no. 2, pp. S105–S114, 2000. View at Google Scholar · View at Scopus
  3. D. R. Arora, V. Gupta, S. Gupta, and B. Arora, “Laboratory diagnosis of acquired immunodeficiency syndrome (AIDS)—a review,” Indian Journal of Sexually Transmitted Diseases, vol. 21, pp. 59–68, 2000. View at Google Scholar
  4. R. O. Valdiserri, M. Moore, A. R. Gerber, C. H. Campbell, B. A. Dillon Jr., and G. R. West, “A study of clients returning for counseling after HIV testing: implications for improving rates of return,” Public Health Reports, vol. 108, no. 1, pp. 12–18, 1993. View at Google Scholar · View at Scopus
  5. Centers for Disease Control and Prevention, “Update: HIV counseling and testing using rapid tests—United States, 1995,” Morbidity Mortality Weekly Report, vol. 47, pp. 211–215.
  6. G. Tao, B. M. Branson, W. J. Kassler, and R. A. Cohen, “Rates of receiving HIV test results: data from the U.S. National Health Interview Survey for 1994 and 1995,” Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol. 22, no. 4, pp. 395–400, 1999. View at Google Scholar · View at Scopus
  7. S. C. Kagulire, P. D. Stamper, P. Opendi et al., “Performance of two commercial immunochromatographic assays for rapid detection of antibodies specific to human immunodeficiency virus types 1 and 2 in serum and urine samples in a rural community-based research setting (Rakai, Uganda),” Clinical and Vaccine Immunology, vol. 14, no. 6, pp. 738–740, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Taye, Y. Woldeamanuel, and E. Kebede, “Diagnostic detection of human immunodeficincy virus type-1 antibodies in urine, Jimma Hospital, south west Ethiopa,” Ethiopian Medical Journal, vol. 44, no. 4, pp. 363–368, 2006. View at Google Scholar · View at Scopus
  9. S. J. S. Pascoe, L. F. Langhaug, J. Mudzori, E. Burke, R. Hayes, and F. M. Cowan, “Field evaluation of diagnostic accuracy of an oral fluid rapid test for HIV, tested at point-of-service sites in rural Zimbabwe,” AIDS Patient Care and STDs, vol. 23, no. 7, pp. 571–576, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. R. L. Hamers, I. H. de Beer, H. Kaura, M. van Vugt, L. Caparos, and T. F. Rinke de Wit, “Diagnostic accuracy of 2 oral fluid-based tests for HIV surveillance in Namibia,” Journal of Acquired Immune Deficiency Syndromes, vol. 48, no. 1, pp. 116–118, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Garg, V. Gautam, P. Sgill, B. Arora, and D. R. Arora, “Comparison of salivary and serum antibody detection in HIV-1 infection by ELISA and rapid methods in India,” Tropical Doctor, vol. 36, no. 2, pp. 108–109, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. J. P. Shott, R. M. Galiwango, and S. J. Reynolds, “A quality management approach to implementing point-of-care technologies for HIV diagnosis and monitoring in sub-Saharan Africa,” Journal of Tropical Medicine, vol. 2012, Article ID 651927, 8 pages, 2012. View at Publisher · View at Google Scholar
  13. 2013, http://www.fda.gov/forconsumers/byaudience/forpatientadvocates/hivandaidsactivities/ucm117922.htm.
  14. R. P. Walensky and A. D. Paltiel, “Rapid HIV testing at home: does it solve a problem or create one?” Annals of Internal Medicine, vol. 145, no. 6, pp. 459–462, 2006. View at Google Scholar · View at Scopus
  15. 2013, http://www.fda.gov/forconsumers/consumerupdates/ucm310545.htm.
  16. http://alerehiv.com/hiv-screening/alere-determine-hiv-12-agab-combo/.
  17. N. P. Pai, R. Barick, J. P. Tulsky et al., “Impact of round-the-clock, rapid oral fluid HIV testing of women in labor in rural India,” PLoS Medicine, vol. 5, no. 5, article e92, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. F. A. Bello, O. O. Ogunbode, O. A. Adesina, O. Olayemi, O. M. Awonuga, and I. F. Adewole, “Acceptability of counselling and testing for HIV infection in women in labour at the University College Hospital, Ibadan, Nigeria,” African Health Sciences, vol. 11, no. 1, pp. 30–35, 2011. View at Google Scholar · View at Scopus
  19. M. H. Cohen, B. Branson, Y. Olszewski et al., “Effective Point—of—care Rapid HIV testing at labour and delivery,” in Proceedings of the 9th Conference on Retroviruses and Opportunistic Infections at Program and Abstracts, Foundation for Retrovirology and Human health, Boston, Mass, USA, 2003.
  20. D. R. Arora and B. Arora, “Retroviridae,” in Textbook of Microbiology, pp. 586–604, CBS Publishers, New Delhi, India, 4th edition, 2012. View at Google Scholar
  21. S. R. Kendrick, K. A. Kroc, D. Withum, R. J. Rydman, B. M. Branson, and R. A. Weinstein, “Outcomes of offering rapid point-of-care HIV testing in a sexually transmitted disease clinic,” Journal of Acquired Immune Deficiency Syndromes, vol. 38, no. 2, pp. 142–146, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. D. R. Arora, V. Gautam, P. S. Gill, B. Arora, and V. Gupta, “Haryana state in India, still a low HIV prevalence state,” Sexually Transmitted Infections, vol. 80, no. 4, pp. 325–326, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. S. C. Kagulire, P. Opendi, P. D. Stamper et al., “Field evaluation of five rapid diagnostic tests for screening of HIV-1 infections in rural Rakai, Uganda,” International Journal of STD and AIDS, vol. 22, no. 6, pp. 308–309, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Kabra and R. Kanugo, “Monitoring quality of HIV testing at point of care facilities in India,” Indian Journal of Medical Microbiology, vol. 30, no. 2, pp. 129–130, 2012. View at Publisher · View at Google Scholar
  25. G. D. Sanders, A. M. Bayoumi, V. Sundaram et al., “Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy,” New England Journal of Medicine, vol. 352, no. 6, pp. 570–585, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. P. A. Volberding and S. G. Deeks, “Antiretroviral therapy and management of HIV infection,” The Lancet, vol. 376, no. 9734, pp. 49–62, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Moore, A. Awor, R. Downing et al., “CD4(+) T cell count monitoring does not accurately identify HIV-infected adults with virologic failure receiving antiretroviral therapy,” Journal of Acquired Immne Deficiency Syndrome, vol. 49, pp. 477–484, 2008. View at Publisher · View at Google Scholar
  28. S. Mtapuri-Zinyowera, M. Chideme, D. Mangwanya et al., “Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe,” Journal of Acquired Immune Deficiency Syndromes, vol. 55, no. 1, pp. 1–7, 2010. View at Google Scholar · View at Scopus
  29. I. V. Jani, N. E. Sitoe, P. L. Chongo et al., “Accurate CD4 T-cell enumeration and antiretroviral drug toxicity monitoring in primary healthcare clinics using point-of-care testing,” AIDS, vol. 25, no. 6, pp. 807–812, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. B. A. Rohrman, V. Leautaud, E. Molyneux, and R. R. Richards-Kortum, “A lateral flow assay for quantitative detection of amplified HIV-1 RNA,” PLoS ONE, vol. 7, no. 9, article e45611, 2012. View at Publisher · View at Google Scholar
  31. 2013, http://www.omegadiagnostics.com/CD4.
  32. D. R. Arora, V. Gautam, P. S. Gill, and N. Mishra, “Recent advances in antiretroviral therapy in HIV infection,” Journal of the Indian Medical Association, vol. 108, no. 1, pp. 29–34, 2010. View at Google Scholar · View at Scopus
  33. C. C. Moore, S. T. Jacob, R. Pinkerton et al., “Point-of-care lactate testing predicts mortality of severe sepsis in a predominantly HIV type 1-infected patient population in Uganda,” Clinical Infectious Diseases, vol. 46, no. 2, pp. 215–222, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Yu, L. Ge, J. Huang, S. Wang, and S. Ge, “Microfluidic paper-based chemiluminescence biosensor for simultaneous determination of glucose and uric acid,” LAb on a Chip, vol. 11, pp. 1286–1291, 2011. View at Publisher · View at Google Scholar
  35. D. R. Arora, V. Gautam, S. Sethi, and B. Arora, “A 16-year study of HIV seroprevalence and HIV-related diseases in a teaching tertiary care hospital in India,” International Journal of STD and AIDS, vol. 15, no. 3, pp. 178–182, 2004. View at Publisher · View at Google Scholar · View at Scopus